Reaction

Intestinal Anastomosis Complication reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 270 reports · 2 co-occurring drugs

As of the last recalculation, Intestinal Anastomosis Complication appears in 270 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is VEDOLIZUMAB (PRR 56.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Vedolizumab5156.056.1
Guselkumab613.213.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.